Super competition as a possible mechanism to pioneer precancerous fields

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 723-728

  Rhiner, Christa ^a   Moreno, Eduardo ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CLINICAL OBSERVATION; DROSOPHILA; EPITHELIUM CELL; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DROSOPHILA; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENES; PRECANCEROUS CONDITIONS;

EID: 65549144381     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp003     Document Type: Review

References (71)

1. Fearon,E.R. et al. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
2. Moreno,E. (2008) Is cell competition relevant to cancer? Nat. Rev. Cancer, 8, 141-147.
3. Okada,H. et al. (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer, 4, 592-603.
4. Merlo,L.M. et al. (2006) Cancer as an evolutionary and ecological process. Nat. Rev. Cancer, 6, 924-935.
5. Loeb,L.A. (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51, 3075-3079.
6. Sparmann,A. et al. (2006) Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer, 6, 846-856.
7. Tomlinson,I. et al. (1999) Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nat. Med., 5, 11-12.
8. Abrams,J.M. (2002) Competition and compensation: Coupled to death in development and cancer. Cell, 110, 403-406.
9. Moolgavkar,S.H. et al. (2003) Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer, 38, 302-306.
10. Tarafa,G. et al. (2008) Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis. Proc. Natl Acad. Sci. USA, 105, 4306-4311.
11. Klein,C.A. (2008) Cancer. The metastasis cascade. Science, 321 1785-1787.
12. Golic,K.G. (1991) Site-specific recombination between homologous chromosomes in Drosophila. Science, 252, 958-961.
13. Struhl,G. et al. (1993) Organizing activity of wingless protein in Drosophila. Cell, 72, 527-540.
14. Morata,G. et al. (1975) Minutes: Mutants of Drosophila autonomously affecting cell division rate. Dev. Biol., 42, 211-221.
15. Simpson,P. et al. (1981) Differential mitotic rates and patterns of growth in compartments in the Drosophila wing. Dev. Biol. 85, 299-308.
16. Lambertsson,A. (1998) The minute genes in Drosophila and their molecular functions. Adv. Genet., 38, 69-134.
17. Diaz,B. et al. (2005) The competitive nature of cells. Exp. Cell Res., 306, 317-322.
18. Oliver,E.R. et al. (2004) Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development, 131, 3907-3920.
19. Johnston,L.A. et al. (1999) Drosophila myc regulates cellular growth during development. Cell, 98, 779-790.
20. Moreno,E. et al. (2004) dMyc transforms cells into super-competitors. Cell, 117, 117-129.
21. de la Cova,C. et al. (2004) Drosophila myc regulates organ size by inducing cell competition. Cell, 117, 107-116.
22. Hariharan,I.K. et al. (2006) Regulation of imaginal disc growth by tumor-suppressor genes in Drosophila. Annu. Rev. Genet., 40, 335-361.
23. Harvey,K. et al. (2007) The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat. Rev. Cancer, 7, 182-191.
24. Saucedo,L.J. et al. (2007) Filling out the Hippo pathway. Nat. Rev. Mol. Cell Biol., 8, 613-621.
25. Tyler,D.M. et al. (2007) Genes affecting cell competition in Drosophila. Genetics, 175, 643-657.
26. Braakhuis,B.J. et al. (2003) A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res., 63, 1727-1730.
27. Moreno,E. et al. (2002) Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature, 416, 755-759.
28. Li,W. et al. (2007) Engulfment is required for cell competition. Cell, 129, 1215-1225.
29. Müller,B. et al. (2003) Conversion of an extracellular Dpp/BMP morphogen gradient into an inverse transcriptional gradient. Cell, 113, 221-233.
30. Grewal,S.S. et al. (2005) Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat. Cell Biol. 7, 295-302.
31. Senoo-Matsuda,N. et al. (2007) Soluble factors mediate competitive and cooperative interactions between cells expressing different levels of Drosophila Myc. Proc. Natl Acad. Sci. USA, 104, 18543-18548.
32. Slaughter,D.P. (1944) The multiplicity of origin of malignant tumors: collective review. Int. Abstr. Surg., 79, 89-98.
33. Slaughter,D.P. et al. (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer, 6, 963-968.
34. Braakhuis,B.J. et al. (2005) Second field tumors: A new opportunity for cancer prevention? Oncologist, 10, 493-500.
35. Ha,P.K. et al. (2003) The molecular biology of mucosal field cancerization of the head and neck. Crit. Rev. Oral Biol. Med., 14, 363-369.
36. Brennan,J.A. et al. (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332, 429-435.
37. Roesch-Ely,M. et al. (2007) Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene, 26, 54-64.
38. Tabor,M.P. et al. (2002) Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am. J. Pathol., 161, 1051-1060.
39. Tabor,M.P. et al. (2004) Genetically altered fields as origin of locally recurrent head and neck cancer: A retrospective study. Clin. Cancer Res., 10, 3607-3613.
40. Ha,P.K. et al. (2002) Mitochondrial C-tract alteration in premalignant lesions of the head and neck: A marker for progression and clonal proliferation. Clin. Cancer Res., 8, 2260-2265.
41. van Houten,V.M. et al. (2002) Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J. Pathol., 198, 476-486.
42. Wong,D.J. et al. (2001) p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res., 61, 8284-8289.
43. Eads,C.A. et al. (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res., 60, 5021-5026.
44. Prevo,L.J. et al. (1999) p53-mutant clones and field effects in Barrett's esophagus. Cancer Res., 59, 4784-4787.
45. Kim,S.K. et al. (2006) The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Biochem. Biophys. Res. Commun., 349, 1032-1040.
46. Kim,J.S. et al. (1997) Amplification of c-erbB-2 proto-oncogene in cancer foci, adjacent normal, metastatic and normal tissues of human primary gastric adenocarcinomas. J. Korean Med. Sci., 12, 311-315.
47. Dakubo,G.D. et al. (2007) Clinical implications and utility of field cancerization. Cancer Cell Int., 7, 2.
48. Durham,S.E. et al. (2003) Mitochondrial DNA damage in non-melanoma skin cancer. Br. J. Cancer, 88, 90-95.
49. Stern,R.S. et al. (2002) p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: Evidence for heterogeneity and field cancerization. J. Invest. Dermatol., 119, 522-526.
50. Chu,T.Y. et al. (1999) Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: A local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer, 24, 127-134.
51. Rosenthal,A.N. et al. (2002) Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int. J. Cancer, 99, 549-554.
52. Höglund,M. (2007) Bladder cancer, a two phased disease? Semin. Cancer Biol., 17, 225-232.
53. Kakizoe,T. (2006) Development and progression of urothelial carcinoma. Cancer Sci., 97, 821-828.
54. Takahashi,T. et al. (1998) Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res., 58, 5835-5841.
55. Shen,L. et al. (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J. Natl Cancer Inst., 97, 1330-1338.
56. Jothy,S. et al. (1996) Field effect of human colon carcinoma on normal mucosa: Relevance of carcinoembryonic antigen expression. Tumour Biol., 17, 58-64.
57. Franklin,W.A. et al. (1997) Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest., 100, 2133-2137.
58. Park,I.W. et al. (1999) Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J. Natl Cancer Inst., 91, 1863-1868.
59. Grepmeier,U. et al. (2005) Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int. J. Oncol., 27, 481-488.
60. Deng,G. et al. (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science, 274, 2057-2059.
61. Heaphy,C.M. et al. (2006) Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int. J. Cancer, 119, 108-116.
62. Försti,A. et al. (2001) Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur. J. Cancer, 37, 1372-1380.
63. Furlan,D. et al. (2006) The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Clin. Cancer Res., 12, 3329-3336.
64. Kitago,M. et al. (2004) Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas. Int. J. Cancer, 110, 177-182.
65. Hanson,J.A. et al. (2006) Gene promoter methylation in prostate tumor-associated stromal cells. J. Natl Cancer Inst., 98, 255-261.
66. Jonason,A.S. et al. (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA, 93, 14025-14029.
67. Izzo,J.G. et al. (1998) Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene, 17, 2313-2322.
68. Tabor,M.P. et al. (2003) Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J. Pathol., 199, 354-360.
69. Maley,C.C. et al. (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res., 64, 7629-7633.
70. Baker,N.E. et al. (2008) Cell competition and its possible relation to cancer. Cancer Res., 68, 5505-5507.
71. Soucek,L. et al. (2008) Modelling Myc inhibition as a cancer therapy. Nature, 455, 679-683.